Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5267-5272

  Somasundaram, Rajasekharan ^a   Jacob, Lutz ^a   Swoboda, Rolf ^a   Caputo, Laura ^a   Song, Hong ^a   Basak, Saroj ^a   Monos, Dimitri ^b   Peritt, David ^a   Marincola, Francesco ^c   Cai, Dewei ^a   Birebent, Brigitte ^a   Bloome, Ellen ^d   Kim, Jin ^a   Berencsi, Klara ^a   Mastrangelo, Michael ^d   Herlyn, Dorothee ^a  

^a WISTAR INSTITUTE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; POKEWEED MITOGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD4; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; HLA-A1 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, NUDE; MICE, SCID; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0037105759     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Model predicting survival in stage I melanoma based on tumor progression
2. An analysis of autologous T-cell anti-tumour responses in colon-carcinoma patients following active specific immunization (ASI)
3. Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: Analysis by cytokine secretion
4. Identification of colon-tumor-associated antigens by T-cell lines derived from tumor-infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumor-cell/bacillus Calmette-Guérin vaccine
5. Isolation and expansion of lymphocytes from gastrointestinal tumour tissue
6. Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: Removal of tumour cells does not affect tumour-specificity
7. Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer
8. Cytotoxic T cell clone against rectal carcinoma induced by stimulation of a patient’s peripheral blood mononuclear cells with autologous cultured tumor cells
9. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
10. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors
11. Selective MHC expression in tumours modulates adaptive and innate antitumour responses
12. The role of transforming growth factor-β (TGF-β) in human cancer
13. + CTL
14. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma
15. Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response
16. Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2
17. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
18. Regulation of immune responses by TGF-β
19. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation
20. Induction of T- and B-cell immunity in colon carcinoma patients by anti-idiotypic antibody
21. Antitumor efficacy of a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in immunocompetent mice bearing syngeneic leukemia
22. + HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells
23. HLA-A2 subtypes are functionally distinct in peptide binding and presentation
24. + immunoregulatory cells
25. + T cells in cancer immunotherapy
26. + HLA class I restricted cytotoxic T cell clones with long term assay and pretreatment of targets with interferon-γ
27. + cytotoxic T cell lines against melanoma
28. +, CD8-T-cell clone restricted by HLA-A2
29. + tumor infiltrating lymphocyte
30. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: Implications in designing antigen-presenting cellbased tumor vaccines
31. + suppressor T cells: More questions than answers
32. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
33. high regulatory cells in human peripheral blood
34. + T cells with regulatory properties isolated from peripheral blood
35. + regulatory T cells
36. The host-tumor immune conflict: From immunosuppression to resistance and destruction
37. + T cells
38. + immunoregulatory T cells is antigen onspecific
39. + regulatory T cells from human peripheral blood
40. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function
41. Oral tolerance: Immune mechanisms and the generation of Th3-type TGF-β-secreting regulatory cells
42. + regulatory T cells induced by an agonist self-peptide
43. Regulatory T cells: Key controllers of immunologic self-tolerance
44. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells